Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
about
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineationDeoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapyReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceAdvances in Radiotherapy Management of Esophageal CancerLocally advanced gastroesophageal junction tumor: a treatment dilemmaFeasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer.Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancerHigh dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature.Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma.Esophageal cancer management controversies: Radiation oncology point of viewRadiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method.Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinomaIncreased risk of death due to heart disease after radiotherapy for esophageal cancer.Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result DatabaseNomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomyPredictors of postoperative complications after trimodality therapy for esophageal cancer.Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study.Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical methodAssociation between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.Radiotherapy treatment of large esophageal leiomyosarcoma: A case report.The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis.Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.Particle Radiation Therapy for Gastrointestinal Cancers.The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?Clinical Benefits of Proton Beam Therapy for Tumors of the Skull Base.Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancerSymptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer.Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.Mortality and cost of radiation therapy for oesophageal cancer according to hospital accreditation level: a nationwide population-based study.Evaluating Factors for Prophylactic Feeding Tube Placement in Gastroesophageal Cancer Patients Undergoing Chemoradiotherapy.French FNCLCC/FFCD 9703 study.Esophageal cancer 2015, more questions than answers.Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study.Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience.
P2860
Q26741018-E023423E-2189-4C4A-AEE8-96B703FD5C5FQ26866394-D1622626-AA10-4356-A9C2-2F42B8D42558Q27009163-3656A081-A72B-4B65-9D7A-AE34583BF3C6Q28078750-382AB57E-8344-4E50-AC53-0C67B0F394E6Q28082596-7D8F1167-5145-4374-BA64-26D768C3C72AQ30413693-D829C418-FEFD-474F-AD56-03B638F2FE6AQ33591706-8652622D-15DE-46FB-A74C-42ED822B1725Q33633596-C47CC944-6F97-4E94-8491-738653CBC5C2Q33778324-8CC30B75-418A-4F22-9E62-922BC4E85BD6Q33823039-2FE0ECFF-BA9A-41FB-84B4-B82A9D6C4CCBQ34049113-640E8FAB-B073-4C1B-A761-74D6CAF85875Q34479911-2731B93B-53A5-4B40-AAC8-D2FCF5089747Q35175248-AAA95615-F436-418F-AD4E-107152B52BFBQ35591822-43CCBB27-F1EA-4EF3-9F18-698D37E50259Q35783521-1A03720D-9383-491D-92D8-C02E0ABEFE1DQ36051703-AFD4580D-92AD-4FCB-B113-9D4AA0008B36Q36062615-73B05482-9868-4B04-99BB-2838126F88D9Q36080134-253914E8-78C0-4B63-AF03-5120FB59CC90Q36093882-4D9052FB-19FF-4544-8059-F4D3885EE223Q37205342-2384972A-86D7-4F18-9FD8-EDFB53677714Q37225652-99D0015C-8884-4203-A0C5-808B71E5B817Q37659287-250FE632-B29E-4273-B73B-9EA2DFE9FF9DQ37701220-8E5CB3A8-91C2-446F-A147-86511E7CC304Q38542080-89C72DE4-B812-4168-8EE4-D2770A43B1F0Q38620687-F95A1801-C9CB-409E-AD1A-2C71FF8FC046Q38623448-DECE3D8E-4912-4459-B8EF-53866CE13640Q38646790-EBCFFFA4-29CF-4EAF-8189-48B364E186E5Q38683954-E8CB4001-CF17-432B-BD44-4FFD408FDA64Q38724284-6BB69F00-55E9-476A-8D48-F5291EB07119Q38854234-F0A0C7E0-88A7-4E06-8C6C-940060FFA453Q38935997-4F2412AF-829E-4834-B572-FA03214FD5DBQ39452568-54BB101D-2833-4E49-9C2F-7CF89EB2C433Q39992067-BF29A07C-60E0-4AA8-AD65-D35DE6F415C6Q40340946-4849E7B3-2816-41C2-99C1-A7112976D9EBQ41495848-1FC71BA7-901D-4653-85FB-6D8FE76C4F10Q42288197-3373580F-5378-4C1D-8168-160FB163A77EQ42358605-91EDBEA4-52B6-42DE-92AE-3691D7DB4A62Q43106527-4D184FBE-20A9-4930-BA9C-A0E05C9130A4Q43267597-68CB5FB1-E91B-4453-AE5E-419B7F725EB0Q43379663-E8D7576E-F9E9-48B6-8F1A-838C67A2508D
P2860
Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Propensity score-based compari ...... therapy for esophageal cancer.
@en
Propensity score-based compari ...... therapy for esophageal cancer.
@nl
type
label
Propensity score-based compari ...... therapy for esophageal cancer.
@en
Propensity score-based compari ...... therapy for esophageal cancer.
@nl
prefLabel
Propensity score-based compari ...... therapy for esophageal cancer.
@en
Propensity score-based compari ...... therapy for esophageal cancer.
@nl
P2093
P2860
P1476
Propensity score-based compari ...... therapy for esophageal cancer.
@en
P2093
Bevan Myles
Jaffer A Ajani
James D Cox
Peter F Thall
Stephen G Swisher
Steven H Lin
Wayne L Hofstetter
Zhongxing Liao
P2860
P304
P356
10.1016/J.IJROBP.2012.02.015
P407
P577
2012-08-03T00:00:00Z